-+ 0.00%
-+ 0.00%
-+ 0.00%

Clear Street Initiates Coverage On Palvella Therapeutics with Buy Rating, Announces Price Target of $200

Benzinga·12/05/2025 13:31:31
语音播报
Clear Street analyst Kaveri Pohlman initiates coverage on Palvella Therapeutics (NASDAQ:PVLA) with a Buy rating and announces Price Target of $200.